NPI: 1568824423 · FAR ROCKAWAY, NY 11691 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/22/2016
| Authorized Official | DEBENEDICTIS, PASQUALE (MEMBER) |
| NPI Enumeration Date | 03/22/2016 |
Other providers sharing the same authorized official: DEBENEDICTIS, PASQUALE
| Provider | City | State | Total Paid |
|---|---|---|---|
| PROSPECT ACQUISITION III LLC | BROOKLYN | NY | $2.38M |
| MORNINGSIDE DIALYSIS CENTER LLC | BRONX | NY | $1.25M |
| MILLS POND DIALYSIS CENTER, LLC | WEST BABYLON | NY | $345K |
| MORNINGSIDE ACQUISITION I, LLC | BRONX | NY | $192K |
| SEA CREST ACQUISITION II, LLC | BROOKLYN | NY | $173K |
| NORWALK ACQUISITION I LLC | NORWALK | CT | $33K |
| STAMFORD ACQUISITION I, LLC | STAMFORD | CT | $423.03 |
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 27,976 | $705K |
| 2020 | 32,003 | $681K |
| 2021 | 15,982 | $299K |
| 2022 | 20,042 | $657K |
| 2023 | 18,844 | $576K |
| 2024 | 16,971 | $465K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90935 | Hemodialysis procedure with single evaluation by a physician | 6,402 | 674 | $1.53M |
| 90937 | 101,819 | 1,951 | $919K | |
| A4657 | Syringe, with or without needle, each | 18,218 | 1,188 | $903K |
| J0882 | Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) | 921 | 319 | $20K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 3,067 | 367 | $13K |
| J1756 | Injection, iron sucrose, 1 mg | 768 | 191 | $2K |
| J1270 | Injection, doxercalciferol, 1 mcg | 623 | 65 | $0.00 |